Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2021 | 1 |
2022 | 1 |
2023 | 3 |
2024 | 2 |
Search Results
6 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
The Diagnostic Value of PSMA PET/CT in Men with Newly Diagnosed Unfavorable Intermediate-Risk Prostate Cancer.
J Nucl Med. 2023 Aug;64(8):1238-1243. doi: 10.2967/jnumed.122.265205. Epub 2023 Jun 29.
J Nucl Med. 2023.
PMID: 37385673
Targeting PSMA Revolutionizes the Role of Nuclear Medicine in Diagnosis and Treatment of Prostate Cancer.
Luining WI, Cysouw MCF, Meijer D, Hendrikse NH, Boellaard R, Vis AN, Oprea-Lager DE.
Luining WI, et al.
Cancers (Basel). 2022 Feb 24;14(5):1169. doi: 10.3390/cancers14051169.
Cancers (Basel). 2022.
PMID: 35267481
Free PMC article.
Review.
Item in Clipboard
Nuclear Imaging for Bone Metastases in Prostate Cancer: The Emergence of Modern Techniques Using Novel Radiotracers.
Luining WI, Meijer D, Dahele MR, Vis AN, Oprea-Lager DE.
Luining WI, et al.
Diagnostics (Basel). 2021 Jan 13;11(1):117. doi: 10.3390/diagnostics11010117.
Diagnostics (Basel). 2021.
PMID: 33450817
Free PMC article.
Review.
Item in Clipboard
Optimization and validation of 18F-DCFPyL PET radiomics-based machine learning models in intermediate- to high-risk primary prostate cancer.
Luining WI, Oprea-Lager DE, Vis AN, van Moorselaar RJA, Knol RJJ, Wondergem M, Boellaard R, Cysouw MCF.
Luining WI, et al.
PLoS One. 2023 Nov 9;18(11):e0293672. doi: 10.1371/journal.pone.0293672. eCollection 2023.
PLoS One. 2023.
PMID: 37943772
Free PMC article.
Item in Clipboard
The Probability of Metastases Within Different Prostate-specific Antigen Ranges Using Prostate-specific Membrane Antigen Positron Emission Tomography in Patients with Newly Diagnosed Prostate Cancer.
Luining WI, Hagens MJ, Meijer D, Ringia JB, de Weijer T, Bektas HO, Ettema RH, Knol RJJ, Roeleveld TA, Srbljin S, Weltings S, Koppes JCC, van Moorselaar RJA, van Leeuwen PJ, Oprea-Lager DE, Vis AN.
Luining WI, et al.
Eur Urol Open Sci. 2023 Dec 22;59:55-62. doi: 10.1016/j.euros.2023.12.001. eCollection 2024 Jan.
Eur Urol Open Sci. 2023.
PMID: 38298765
Free PMC article.
Item in Clipboard
A Comparison of Globally Applied Prognostic Risk Groups and the Prevalence of Metastatic Disease on Prostate-specific Membrane Antigen Positron Emission Tomography in Patients with Newly Diagnosed Prostate Cancer.
Luining WI, Boevé LMS, Hagens MJ, Meijer D, de Weijer T, Ettema RH, Knol RJJ, Roeleveld TA, Srbljin S, Weltings S, Koppes JCC, van Moorselaar RJA, van Leeuwen PJ, Cysouw MCF, Oprea-Lager DE, Vis AN.
Luining WI, et al.
Eur Urol Oncol. 2024 Apr 30:S2588-9311(24)00097-X. doi: 10.1016/j.euo.2024.04.005. Online ahead of print.
Eur Urol Oncol. 2024.
PMID: 38693019
Item in Clipboard
Cite
Cite